Skip to main content

Animations

MJFF Publications

1071 - 1080 of 8571 Results
Title
Year
  • Year
  • 2019
  • 2019
  • 2017
  • 2018
  • 2018
  • 2023
  • 2018
  • 2020
  • 2023
  • 2017
  • Summary Details
    OPEN
    Title: Longitudinal analyses of cerebrospinal fluid α‐Synuclein in prodromal and early Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.27806
    Citation Count: 108
  • Summary Details
    OPEN
    Title: Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competition
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2019.104577
    Citation Count: 40
  • Summary Details
    RESTRICTED
    Title: Serum lipid alterations in GBA-associated Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.08.026
    Best OA location URL:
    Citation Count: 78
  • Summary Details
    OPEN
    Title: Interactome Screening Identifies the ER Luminal Chaperone Hsp47 as a Regulator of the Unfolded Protein Response Transducer IRE1α
    Journal Name: Molecular Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.molcel.2017.12.028
    Citation Count: 154
  • Summary Details
    RESTRICTED
    Title: Intranasal delivery of hGDNF plasmid DNA nanoparticles results in long-term and widespread transfection of perivascular cells in rat brain
    Journal Name: Nanomedicine: Nanotechnology, Biology and Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.nano.2018.11.006
    Best OA location URL:
    Citation Count: 26
  • Summary Details
    OPEN
    Title: GABAA Receptor Benzodiazepine Binding Sites and Motor Impairments in Parkinson’s Disease
    Journal Name: Brain Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/brainsci13121711
    Citation Count: 5
  • Summary Details
    OPEN
    Title: USP 14 inhibition corrects an in vivo model of impaired mitophagy
    Journal Name: EMBO Molecular Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/emmm.201809014
    Citation Count: 93
  • Summary Details
    RESTRICTED
    Title: The footprint of orthostatic hypotension in parkinsonian syndromes
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.029
    Best OA location URL:
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Super-Resolution-Chip: an in-vitro platform that enables super-resolution microscopy of co-cultures and 3D systems
    Journal Name: Biomedical Optics Express
    Publisher: Optica Publishing Group
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1364/boe.498038
    Citation Count: 1
  • Summary Details
    OPEN
    Title: The lysosomal enzyme alpha-Galactosidase A is deficient in Parkinson's disease brain in association with the pathologic accumulation of alpha-synuclein
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.nbd.2017.11.006
    Citation Count: 44
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.